|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-3-6
|
|
pubmed:abstractText |
To select the optimal treatment according to the degree of malignancy of neuroblastoma, it is essential to accurately and rapidly identify any genetic abnormalities associated with the prognosis. This study aims to assess the correlation between the combination of prognostic factors and the biologic findings of neuroblastoma using a highly sensitive analysis of prognostic factors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing,
http://linkedlifedata.com/resource/pubmed/chemical/BIN1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/BIRC5 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Genetic Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibitor of Apoptosis Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/MYCN protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Microtubule-Associated Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1531-5037
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
560-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16516635-Adaptor Proteins, Signal Transducing,
pubmed-meshheading:16516635-Child,
pubmed-meshheading:16516635-Child, Preschool,
pubmed-meshheading:16516635-Female,
pubmed-meshheading:16516635-Gene Dosage,
pubmed-meshheading:16516635-Gene Expression Profiling,
pubmed-meshheading:16516635-Genetic Markers,
pubmed-meshheading:16516635-Humans,
pubmed-meshheading:16516635-Infant,
pubmed-meshheading:16516635-Infant, Newborn,
pubmed-meshheading:16516635-Inhibitor of Apoptosis Proteins,
pubmed-meshheading:16516635-Male,
pubmed-meshheading:16516635-Microtubule-Associated Proteins,
pubmed-meshheading:16516635-Neoplasm Proteins,
pubmed-meshheading:16516635-Neoplasm Staging,
pubmed-meshheading:16516635-Neuroblastoma,
pubmed-meshheading:16516635-Nuclear Proteins,
pubmed-meshheading:16516635-Oncogene Proteins,
pubmed-meshheading:16516635-Polymerase Chain Reaction,
pubmed-meshheading:16516635-Prognosis,
pubmed-meshheading:16516635-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16516635-Sensitivity and Specificity,
pubmed-meshheading:16516635-Survival Analysis,
pubmed-meshheading:16516635-Tumor Suppressor Proteins
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors.
|
|
pubmed:affiliation |
Department of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan. taji@pedsurg.med.kyusyu-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
